STAT

Trump promised to bring pharma to justice. His speech sent drug stocks soaring

President Trump promised to deliver a speech that would put to justice the pharma companies he claimed were gouging consumers. But his long-awaited remarks sent biopharma stocks skyward instead.

For months, President Trump promised to deliver a speech that would put to justice the pharma companies he claimed were gouging consumers. But his long-awaited remarks, delivered Friday, sent biopharma stocks skyward instead.

Trump did not call that marked his presidential campaign.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks